Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 18/20 | 0.56 |
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.40 |
| ▸ | PARP2 | Q9UGN5 | 4/20 | 0.39 |
| ▸ | CDC7 | O00311 | 1/20 | 0.38 |
| ▸ | PIM1 | P11309 | 1/20 | 0.38 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.38 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7411360 | 0.80 | PARP1 (0.56) | PARP1PARP2 | |
| SCHEMBL6869338 | 0.79 | PARP1 (0.69) | PARP1PARP2PIM1 | |
| SCHEMBL7409889 | 0.75 | PARP1 (0.50) | PARP1SCN10APARP2CDC7PIM1 | |
| SCHEMBL633643 | 0.72 | PARP1 (1.00) | PARP1PARP2 | |
| SCHEMBL630259 | 0.72 | PARP1 (1.00) | PARP1PARP2 | |
| SCHEMBL7702651 | 0.72 | PARP1 (1.00) | PARP1PARP2 | |
| SCHEMBL7417446 | 0.71 | HTR3A (0.40) | PARP1 | |
| SCHEMBL7415578 | 0.70 | PIM1 (0.40) | PARP1PIM1 | |
| SCHEMBL7416833 | 0.70 | PARP1 (0.57) | PARP1PARP2 | |
| SCHEMBL630980 | 0.69 | PARP1 (1.00) | PARP1PARP2PIM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1133477-A1 | SUBSTITUTED BENZIMIDAZOLES AND THEIR USE AS PARP INHIBITORS | BASF AKTIENGESELLSCHAFT (DE) | 2001-09-19 | — | — | EP | disclosed |
| WO-2000032579-A1 | SUBSTITUTED BENZIMIDAZOLES AND THEIR USE AS PARP INHIBITORS | BASF AKTIENGESELLSCHAFT (DE) | 2000-06-08 | — | — | WO | disclosed |